OLVIG
NVAX icon

Oliver Lagore Vanvalin Investment Group’s Novavax NVAX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15
Closed -$154 – 724
2022
Q4 		$154 Hold
15
– – ﹤0.01% 641
2022
Q3 		$0 Hold
15
– – ﹤0.01% 704
2022
Q2 		$1K Hold
15
– – ﹤0.01% 573
2022
Q1 		$1K Buy
+15
New +$1.34K ﹤0.01% 540

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's NVAX Position: Q1 2023 in Review

Oliver Lagore Vanvalin Investment Group sold out of Novavax (NVAX) in Q1 2023, closing a stake of 15 shares — an estimated $154 sold.

Oliver Lagore Vanvalin Investment Group first reported a position in NVAX in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q2 2022. 223 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 15 Novavax shares in Q1 2023, an estimated $154.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Novavax in Q1 2022 and held it in 4 quarters.
  • Oliver Lagore Vanvalin Investment Group's Novavax position peaked at $1K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q1 2023, filed 20 Jun 2023.